{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:14:06Z","timestamp":1793366046886,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","award":["75A50121C00077"],"award-info":[{"award-number":["75A50121C00077"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["Other Transaction number W15QKN-16-9-1002"],"award-info":[{"award-number":["Other Transaction number W15QKN-16-9-1002"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recent outbreaks of Ebola virus disease (EVD) and Marburg virus disease (MVD) in sub-Saharan Africa illustrate the need to better understand animal reservoirs, burden of disease, and human transmission of filoviruses. This protocol outlines a systematic literature review to assess the prevalence of filoviruses that infect humans in sub-Saharan Africa. A secondary aim is to qualitatively describe and evaluate the assays used to assess prevalence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The data sources for this systematic review include PubMed, Embase, and Web of Science. Titles, abstracts, and full texts will be reviewed for inclusion by a primary reviewer and then by a team of secondary reviewers, and data will be extracted using a pre-specified and piloted data extraction form. The review will include human cross-sectional studies, cohort studies, and randomized controlled trials conducted in sub-Saharan Africa up until March 13, 2024 that have been published in peer-reviewed scientific journals, with no language restrictions. Prevalence will be stratified by pathogen, population, assay, and sampling methodology and presented in forest plots with estimated prevalence and 95% confidence intervals. If there are enough studies within a stratum, I<jats:sup>2<\/jats:sup> statistics will be calculated (using R statistical software), and data will be pooled if heterogeneity is low. In addition, assays used to detect infection will be evaluated. All studies included in the review will be assessed for quality and risk of bias using the JBI Prevalence Critical Appraisal Tool and for certainty using the GRADE certainty ratings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Accurately measuring the rate of exposure to filoviruses infecting humans in sub-Saharan Africa using prevalence provides an essential understanding of natural history, transmission, and the role of subclinical infection. This systematic review will identify research gaps and provide directions for future research seeking to improve our understanding of filovirus infections. Understanding the natural history, transmission, and the role of subclinical infection is critical for predicting the impact of an intervention on disease burden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic Review Registration<\/jats:title>\n                <jats:p>In accordance with the guidelines outlined in the PRISMA-P methodology, this protocol was registered with PROSPERO on April 7, 2023 (ID: CRD42023415358).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-024-02626-w","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:02:14Z","timestamp":1723719734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of human filovirus infections in sub-Saharan Africa: A systematic review and meta-analysis protocol"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9915-9091","authenticated-orcid":false,"given":"Christopher S.","family":"Semancik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Postler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Zaric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Kuteesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Malkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kilianski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati B.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanna C.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"2626_CR1","unstructured":"Feldmann H, Klenk HD. Filoviruses. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 72. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK8129\/)."},{"key":"2626_CR2","doi-asserted-by":"publisher","unstructured":"Languon S, Quaye O. Filovirus Disease Outbreaks: A Chronological Overview. Virology : research and treatment. 2019;10:1178122X19849927. https:\/\/doi.org\/10.1177\/1178122X19849927.","DOI":"10.1177\/1178122X19849927"},{"key":"2626_CR3","doi-asserted-by":"publisher","unstructured":"Kuhn, J. H., Adkins, S., Alkhovsky, S. V., Av\u0161i\u010d-\u017dupanc, T., Ayll\u00f3n, M. A., Bahl, J., Balkema-Buschmann, A., Ballinger, M. J., Bandte, M., Beer, M., Bejerman, N., Bergeron, \u00c9., Biedenkopf, N., Bigarr\u00e9, L., Blair, C. D., Blasdell, K. R., Bradfute, S. B., Briese, T., Brown, P. A., Bruggmann, R., \u2026 \u00d8kland, A. L. 2022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. Archives of virology. 2022;167(12), 2857\u20132906. https:\/\/doi.org\/10.1007\/s00705-022-05546-z.","DOI":"10.1007\/s00705-022-05546-z"},{"key":"2626_CR4","unstructured":"Ebola Virus Disease. PAHO\/WHO | Pan American Health Organization. (n.d.). Retrieved April 5, 2023, from https:\/\/www.paho.org\/en\/topics\/ebola-virus-disease#:~:text=The%20average%20EVD%20case%20fatality,to%2090%25%20in%20past%20outbreaks."},{"key":"2626_CR5","unstructured":"World Health Organization. (n.d.). Marburg virus disease. World Health Organization. Retrieved April 5, 2023, from https:\/\/www.who.int\/health-topics\/marburg-virus-disease#tab=tab_1."},{"key":"2626_CR6","unstructured":"World Health Organization. Marburg Virus Disease - Ghana. World Health Organization. 2022. Retrieved April 5, 2023, from https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON409."},{"key":"2626_CR7","unstructured":"World Health Organization. Marburg virus disease - Equatorial Guinea. World Health Organization. 2023. Retrieved April 27, 2023, from https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON459#:~:text=This%20brings%20the%20total%20to,all%20probable%20cases%20are%20dead."},{"key":"2626_CR8","unstructured":"Centers for Disease Control and Prevention. History of Ebola Disease Outbreaks. Centers for Disease Control and Prevention. 2023. Retrieved May 4, 2023, from https:\/\/www.cdc.gov\/vhf\/ebola\/history\/chronology.html."},{"key":"2626_CR9","unstructured":"Centers for Disease Control and Prevention. Marburg Virus Disease Outbreaks. Centers for Disease Control and Prevention. 2023. Retrieved May 4, 2023, from https:\/\/www.cdc.gov\/vhf\/marburg\/outbreaks\/chronology.html."},{"key":"2626_CR10","doi-asserted-by":"publisher","unstructured":"Lamontagne, F., Fowler, R. A., Adhikari, N. K., Murthy, S., Brett-Major, D. M., Jacobs, M., Uyeki, T. M., Vallenas, C., Norris, S. L., Fischer, W. A., 2nd, Fletcher, T. E., Levine, A. C., Reed, P., Bausch, D. G., Gove, S., Hall, A., Shepherd, S., Siemieniuk, R. A., Lamah, M. C., Kamara, R., \u2026 Guyatt, G. H. Evidence-Based Guidelines for Supportive Care of Patients with Ebola Virus Disease. Lancet (London, England), 2018;391(10121):700\u2013708. https:\/\/doi.org\/10.1016\/S0140-6736(17)31795-6.","DOI":"10.1016\/S0140-6736(17)31795-6"},{"issue":"12","key":"2626_CR11","doi-asserted-by":"publisher","first-page":"e1010078","DOI":"10.1371\/journal.ppat.1010078","volume":"17","author":"C Woolsey","year":"2021","unstructured":"Woolsey C, Geisbert TW. Current state of Ebola virus vaccines: A snapshot. PLoS Pathog. 2021;17(12):e1010078. https:\/\/doi.org\/10.1371\/journal.ppat.1010078.","journal-title":"PLoS Pathog"},{"key":"2626_CR12","unstructured":"World Health Organization. (n.d.). Who technical advisory group \u2013 candidate vaccine prioritization.  summary of the evaluations and recommendations on the four Marburg vaccines. World Health Organization. Retrieved May 4, 2023, from https:\/\/www.who.int\/publications\/m\/item\/who-technical-advisory-group---candidate-vaccine-prioritization.--summary-of-the-evaluations-and-recommendations-on-the-four-marburg-vaccines."},{"key":"2626_CR13","unstructured":"World Health Organization. (n.d.). Sudan ebolavirus candidate vaccines what additional research should be conducted to advance the evaluation of these candidate vaccines? World Health Organization. Retrieved May 4, 2023, from https:\/\/www.who.int\/publications\/m\/item\/sudan-ebolavirus-candidate-vaccines-what-additional-research-should-be-conducted-to-advance-the-evaluation-of-these-candidate-vaccines."},{"key":"2626_CR14","doi-asserted-by":"publisher","unstructured":"Cross, R. W., Longini, I. M., Becker, S., Bok, K., Boucher, D., Carroll, M. W., D\u00edaz, J. V., Dowling, W. E., Draghia-Akli, R., Duworko, J. T., Dye, J. M., Egan, M. A., Fast, P., Finan, A., Finch, C., Fleming, T. R., Fusco, J., Geisbert, T. W., Griffiths, A., G\u00fcnther, S., \u2026 Marzi, A. An introduction to the Marburg virus vaccine consortium, MARVAC. PLoS pathogens, 2022;18(10):e1010805. https:\/\/doi.org\/10.1371\/journal.ppat.1010805.","DOI":"10.1371\/journal.ppat.1010805"},{"key":"2626_CR15","doi-asserted-by":"publisher","unstructured":"Cooper, C. L., Morrow, G., Yuan, M., Coleman, J. W., Hou, F., Reiserova, L., Li, S. L., Wagner, D., Carpov, A., Wallace-Selman, O., Valentin, K., Choi, Y., Wilson, A., Kilianski, A., Sayeed, E., Agans, K. N., Borisevich, V., Cross, R. W., Geisbert, T. W., Feinberg, M. B., \u2026 Parks, C. L. Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials. Vaccines. 2022;10(10):1582. https:\/\/doi.org\/10.3390\/vaccines10101582.","DOI":"10.3390\/vaccines10101582"},{"key":"2626_CR16","unstructured":"Centers for Disease Control and Prevention. Filoviruses (Filoviridae). Centers for Disease Control and Prevention. 2021. Retrieved May 25, 2023, from https:\/\/www.cdc.gov\/vhf\/virus-families\/filoviridae.html."},{"issue":"6","key":"2626_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1473-3099(17)30111-1","volume":"17","author":"JR Glynn","year":"2017","unstructured":"Glynn JR, Bower H, Johnson S, Houlihan CF, Montesano C, Scott JT, Semple MG, Bangura MS, Kamara AJ, Kamara O, Mansaray SH, Sesay D, Turay C, Dicks S, Wadoum REG, Colizzi V, Checchi F, Samuel D, Tedder RS. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infect Dis. 2017;17(6):645\u201353. https:\/\/doi.org\/10.1016\/S1473-3099(17)30111-1.","journal-title":"Lancet Infect Dis"},{"issue":"9222","key":"2626_CR18","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/s0140-6736(00)02405-3","volume":"355","author":"EM Leroy","year":"2000","unstructured":"Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud- Soukate J, Capron M, Debr\u00e9 P, McCormick JB, Georges AJ. Human asymptomatic Ebola infection and strong inflammatory response. Lancet (London, England). 2000;355(9222):2210\u20135. https:\/\/doi.org\/10.1016\/s0140-6736(00)02405-3.","journal-title":"Lancet (London, England)"},{"key":"2626_CR19","doi-asserted-by":"publisher","unstructured":"Bower H, Glynn JR. A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection. Scientific Data.\u00a02017;4(1). https:\/\/doi.org\/10.1038\/sdata.2016.133.","DOI":"10.1038\/sdata.2016.133"},{"key":"2626_CR20","doi-asserted-by":"publisher","unstructured":"Nyakarahuka, L., Kankya, C., Krontveit, R., Mayer, B., Mwiine, F. N., Lutwama, J., & Skjerve, E. How severe and prevalent are ebola and Marburg viruses? A systematic review and meta- analysis of the case fatality rates and Seroprevalence. BMC Infectious Diseases. 2016;16(1). https:\/\/doi.org\/10.1186\/s12879-016-2045-6.","DOI":"10.1186\/s12879-016-2045-6"},{"key":"2626_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","volume":"14","author":"AM Methley","year":"2014","unstructured":"Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14:579. https:\/\/doi.org\/10.1186\/s12913-014-0579-0.","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"2626_CR22","doi-asserted-by":"publisher","first-page":"e27319","DOI":"10.1371\/journal.pone.0027319","volume":"6","author":"A Booth","year":"2011","unstructured":"Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. Establishing a minimum dataset for prospective registration of systematic reviews: an international consultation. PLoS ONE. 2011;6(11):e27319. https:\/\/doi.org\/10.1371\/journal.pone.0027319.","journal-title":"PLoS ONE"},{"key":"2626_CR23","doi-asserted-by":"crossref","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Explanation and Elaboration (PRESS E&E). CADTH Methods and Guidelines. 2016. Retrieved February 22, 2023, from https:\/\/www.cadth.ca\/sites\/default\/files\/pdf\/CP0015_PRESS_Update_Report_2016.pdf.","DOI":"10.1016\/j.jclinepi.2016.01.021"},{"key":"2626_CR24","doi-asserted-by":"publisher","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014A Web and Mobile App for Systematic Reviews. Systematic Reviews. 2016;5(1). https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","DOI":"10.1186\/s13643-016-0384-4"},{"key":"2626_CR25","unstructured":"Joanna Briggs Institute. Checklist for Prevalence Studies. Joanna Briggs Institute. 2017. Retrieved February 22, 2023, from https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Prevalence_Studies2017_0.pdf."},{"issue":"1","key":"2626_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12874-020-00975-3","volume":"20","author":"Borges Migliavaca, C., Stein, C., Colpani, V., Barker, T. H., Munn, Z., Falavigna, M., & Prevalence Estimates Reviews \u2013 Systematic Review Methodology Group (PERSyst)","year":"2020","unstructured":"Borges Migliavaca, C., Stein, C., Colpani, V., Barker, T. H., Munn, Z., Falavigna, M., & Prevalence Estimates Reviews \u2013 Systematic Review Methodology Group (PERSyst). How are systematic reviews of prevalence conducted? A methodological study. BMC Med Res Methodol. 2020;20(1):96. https:\/\/doi.org\/10.1186\/s12874-020-00975-3.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"2626_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/eb-2014-101794","volume":"17","author":"A Nikolakopoulou","year":"2014","unstructured":"Nikolakopoulou A, Mavridis D, Salanti G. How to interpret meta-analysis models: fixed effect and random effects meta-analyses. Evid Based Ment Health. 2014;17(2):64. https:\/\/doi.org\/10.1136\/eb-2014-101794.","journal-title":"Evid Based Ment Health"},{"key":"2626_CR28","unstructured":"BMJ Publishing Group. (n.d.). What is GRADE?. BMJ Best Practice. https:\/\/bestpractice.bmj.com\/info\/us\/toolkit\/learn-ebm\/what-is-grade\/."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02626-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-024-02626-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02626-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:02:56Z","timestamp":1723719776000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-024-02626-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2626"],"URL":"https:\/\/doi.org\/10.1186\/s13643-024-02626-w","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"22 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data in this systematic review will be obtained from publicly available, published, peer-reviewed publications.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"There are no identifying data in this study. All data will be obtained from publicly available, published, peer-reviewed publications. All authors consent and approve the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}